Status:
COMPLETED
Postoperative Opt-In Narcotic Treatment Study
Lead Sponsor:
University of California, Los Angeles
Conditions:
Postoperative Pain
Narcotic Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
pills go unused, generating waste and leaving an opportunity for misuse and abuse. In a recent study, researchers let patients choose what medications to go home with after surgery. After their thyro...
Detailed Description
Due to the current opioid epidemic, there has been increased focus on the prescribing patterns of physicians and greater incentive to reduce the amount of narcotic pain medication prescribed. A prosp...
Eligibility Criteria
Inclusion
- Eligibility for outpatient parathyroidectomy, thyroidectomy or neck dissection Patients aged 18 or older English-speaking: Our provided materials (video instruction, written instructions, survey material) will be in English and we want to ensure clear communication with our study subjects. Once we have demonstrated feasibility of such an opt-in policy with our English-speaking subjects, we will expand our materials to additional languages.
Exclusion
- Prior history of narcotic use Inpatient admission after surgery
Key Trial Info
Start Date :
June 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04710069
Start Date
June 26 2020
End Date
January 30 2021
Last Update
March 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Medical Center
Los Angeles, California, United States, 90095